THE EFFECT OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-DELTA AGONIST ON ACTIVATED INFLAMMASOME IN MODELS OF NONALCOHOLIC FATTY LIVER DISEASE

被引：0
|
作者：
Lee, H. J. [1 ]
Yeon, J. E. [1 ]
Ko, E. J. [1 ]
Yoon, E. L. [1 ]
Suh, S. J. [1 ]
Kang, K. [1 ]
Kim, H. R. [1 ]
Kang, S. H. [1 ]
Yoo, Y. J. [1 ]
Je, J. [1 ]
Kim, J. H. [1 ]
Seo, Y. S. [1 ]
Yim, H. J. [1 ]
Um, S. H. [1 ]
Byun, K. S. [1 ]
机构：
[1] Korea Univ, Coll Med, Dept Internal Med, Seoul 136705, South Korea
来源：
JOURNAL OF HEPATOLOGY | 2014年 / 60卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(14)60418-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P256
引用
收藏
页码：S150 / S150
页数：1
相关论文
共 50 条
  • [21] Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD)
    Qiu, Yuan-Ye
    Zhang, Jing
    Zeng, Fan-Yi
    Zhu, Yi Zhun
    PHARMACOLOGICAL RESEARCH, 2023, 192
  • [22] Muraglitazar - A dual peroxisome proliferator-activated receptor agonist
    Kirwin, J
    Van Amburgh, J
    FORMULARY, 2005, 40 (09) : 285 - +
  • [23] Effect of a Peroxisome Proliferator-Activated Receptor Beta/Delta Agonist on Lipoprotein Kinetics in the Metabolic Syndrome
    Ooi, Esther M.
    Watts, Gerald F.
    Chan, Dick C.
    Staels, Bart
    Caron, Sandrine
    Sprecher, Dennis
    Barrett, P. Hugh R.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (07) : E32 - E32
  • [24] Peroxisome proliferator-activated receptor alpha and estrogen related receptor alpha ligand combinations ameliorate nonalcoholic fatty liver disease
    Antwi, Milton
    Lefere, Sander
    Koorneef, Lisa
    Heldens, Anneleen
    Onghena, Louis
    Geerts, Anja
    Devisscher, Lindsey
    De Bosscher, Karolien
    JOURNAL OF HEPATOLOGY, 2023, 78 : S743 - S743
  • [25] A role of peroxisome proliferator-activated receptor γ in non-alcoholic fatty liver disease
    Skat-Rordam, Josephine
    Ipsen, David Hojland
    Lykkesfeldt, Jens
    Tveden-Nyborg, Pernille
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 124 (05) : 528 - 537
  • [26] Effect of peroxisome proliferator-activated receptor-delta ligand on IL-8 expression in NFkappaΒ dependant manner
    Hrgovic, I.
    Meissner, M.
    Michailidou, D.
    Stein, M.
    Kaufmann, R.
    Gille, J.
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2007, 86 : 40 - 40
  • [27] Peroxisome proliferator-activated receptor γ and metabolic disease
    Willson, TM
    Lambert, MH
    Kliewer, SA
    ANNUAL REVIEW OF BIOCHEMISTRY, 2001, 70 : 341 - 367
  • [28] A SPECIFIC PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)-δ AGONIST ATTENUATES LIVER FIBROGENESIS
    Iwaisako, Keiko
    Taura, Kojiro
    Paik, Yonghan
    Brenner, David A.
    Schnabl, Bernd
    HEPATOLOGY, 2009, 50 (04) : 405A - 406A
  • [29] Liver X receptor and peroxisome proliferator-activated receptor agonist from Cornus alternifolia
    He, Yang-Qing
    Ma, Guo-Yi
    Peng, Jiang-nan
    Ma, Zhan-Ying
    Hamann, Mark T.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2012, 1820 (07): : 1021 - 1026
  • [30] Peroxisome Proliferator-Activated Receptor Beta/Delta Agonist Suppresses Inflammation and Promotes Neovascularization
    Tobita, Yutaro
    Arima, Takeshi
    Nakano, Yuji
    Uchiyama, Masaaki
    Shimizu, Akira
    Takahashi, Hiroshi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (15) : 1 - 13
12345